Skip to content
★ Sign in to follow
HB

H Barron

CEO
GlaxoSmithKline plc
Total declarations
1
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 17 Apr 2018 for GlaxoSmithKline plc, €122k.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

No signal scores available.

H Barron: trading record in brief

Our data holds just one disclosure by H Barron, dated 17 April 2018, reporting a share grant worth €122k in GlaxoSmithKline plc. Further filings will be added here. This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.

Companies and markets linked to H Barron

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total
  • ◆
    Chief Scientific Officer and President, R&DExecutivesGlaxoSmithKline plc
    150,763 USD30FCA-NSM
    3,711.539 shares@ US$40.62100.0% of flowNew York Stock Exchange (XNYS)ISIN US37733W1053FCA-NSM:LSE20180417132007_13607850_20200330111353271_11861-12

1 of 1 declaration